Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
- Status
- COMPLETED
- Phase
- PHASE3
A Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan After Single Dosing in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Liraglutide in Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A
- Status
- COMPLETED
- Phase
- PHASE1
A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A
- Status
- COMPLETED
- Phase
- PHASE3
A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
- Status
- COMPLETED
- Phase
- PHASE3
A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
- Status
- COMPLETED
- Phase
- PHASE3
A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects.
- Status
- COMPLETED
- Phase
- PHASE1
Lifestyle Modification and Liraglutide
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only
- Status
- COMPLETED
- Phase
- PHASE3
A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification
- Status
- COMPLETED
- Phase
- PHASE3
Liraglutide 3 mg for Knee Osteoarthritis
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3